The FDA has approved a new drug called zolbetuximab designed to attack a novel target that’s in a type of stomach cancer.

Initial OnKure Therapeutics, Inc. data from PIKture-01 study on OKI-219 for PI3Ka-H1047R breast cancer expected in Q4, 2024.

Trodelvy shows effectiveness in real-world breast cancer treatment, even after receiving Enhertu therapy. For patients with ...

A patient at The Meadows Psychiatric Center was arrested Wednesday for an assault that state police at Rockview said sent at ...

Could the drug that's changing the weight loss industry also protect older adults against the most common form of dementia? Scientists have exciting news about semaglutide.

The UK medicines regulator has asked doctors to look out for “signs of misuse” of weight loss drugs among their patients. It ...

Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...

Therapists struck off for serious misconduct, including the sexual exploitation of vulnerable clients, are still operating ...

Anyone with outdated or unwanted prescription drugs or over-the-counter medications can bring them to Rapides Regional ...

Researchers from the University of Waterloo have developed a new technology that can hold an entire course of antibiotics in ...

People with Type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer's compared ...

Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the ...